Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pooled Safety Summary for Patients Treated with the CD22-Directed Cytotoxin Moxetumomab Pasudotox-tdfk Kreitman, R., Coutre, S., Elesinmogun, C., Kuptsova-Clarkson, N., Li, X., Pastan, I., Gladstone, D. CIG MEDIA GROUP, LP. 2019: S275
View details for DOI 10.1016/j.clml.2019.07.207
View details for Web of Science ID 000483480700245